A new study by researchers at a Canadian biotech company showed a small, but statistically significant increase in the risk of a rare form of benign prostatic hypertrophy (BPH), the most common type of enlarged prostate, compared with the general population.
In their study, researchers looked at data from more than 1,600 patients who had both BPH and a history of prostate cancer in the past year and found that the risk was higher in patients who had both.
Researchers used a combination of the Prostate Cancer Prevention Trial (PCPT) and the European Society of Urology (ESUE) prostate cancer risk reduction trial to determine whether the increased risk of the disease in these patients was due to either the increase in BPH risk or a change in lifestyle.
"The findings are important for physicians to be aware of the importance of the diagnosis and treatment of BPH and also to be aware of the potential role of lifestyle modifications in this population," said study co-author Dr. James T. Hoe, a prostate health expert at the University of Texas Health Science Center at San Antonio.
In the PCPT trial, patients who were on Proscar and had undergone an operation to remove the prostate gland were given the option of a daily dose of finasteride, a drug similar to Propecia in the treatment of BPH. Finasteride was not included in the trial because it has not been approved for the treatment of BPH, and patients should receive an evaluation for prostate cancer and the presence of BPH.
"The findings are important for physicians to be aware of the importance of the diagnosis and treatment of BPH and also to be aware of the potential role of lifestyle modifications in this population," said co-author Dr. Robert B. Johnson, a urologist at the University of North Texas Medical Center in San Antonio.
The authors of the PCPT trial compared the risk of BPH in patients treated with finasteride with the risk of BPH in patients treated with the same drug. Finasteride increased the risk of both conditions by 5.4 times.
The researchers observed a similar increase in the risk of prostate cancer in both finasteride and the placebo patients. In the PCPT trial, those receiving finasteride had a slightly higher risk of developing BPH, but the risk was still statistically significant. The risk of BPH was still statistically significant in the finasteride group, but the risk was still small in the placebo group.
Although the study has limitations, the results of the current meta-analysis showed that the increased risk of prostate cancer associated with the use of finasteride was more than 5 times greater in the finasteride group than the placebo group.
"The meta-analysis is a reasonable and consistent result of the current meta-analysis, but the conclusions may not be generalizable to all patients as the results of the meta-analysis were derived from multiple populations," said co-author Dr. Hoe, a urologist at the University of Texas Health Science Center at San Antonio.
The study was performed in part at the University of Toronto, Canada.
The U. S. Food and Drug Administration (FDA) recently approved Propecia for the treatment of male pattern hair loss in men.
A clinical trial of Propecia in men with an enlarged prostate was conducted by the Canadian National Prostate Cancer Trialists’ Association (NCPT-C) in September 2015.The North American trial showed that the risk of prostate cancer was higher in men who had both Propecia and finasteride compared to men who had either the placebo or the active drug.
The NCPT-C study involved more than 1,600 men who had both Propecia and finasteride treatment. The primary endpoint was to compare the risk of developing a new condition of prostate cancer in men who had either Propecia or finasteride treatment versus men who had either the placebo or the active drug.
Results showed that there was a significant increase in the risk of prostate cancer in men who had both Propecia and finasteride treatment compared with those who had either the placebo or the active drug.
The study also showed that the risk of BPH was increased in men who had both Propecia and finasteride treatment compared to those who had either the placebo or the active drug.
"The results are important for physicians to be aware of the importance of the diagnosis and treatment of BPH and also to be aware of the potential role of lifestyle changes in this population," said co-author Dr. Robert J. A.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Human Hair 5% w/wThis product is a DHEB-Stable Prostate Specific Antigen (DHEB-SAF) product, specifically a 5-HTP oral tablet, in the treatment of benign prostatic hyperplasia (BPH) and other urinary symptoms. BPH is a common male reproductive health condition, characterized by an enlarged prostate that can lead to significant damage to the urinary system. BPH symptoms include difficulty starting to relieve urinary symptoms, frequenting urination, and need to urinate frequently. DHEB-SAF is a hormone therapy that is used to treat enlarged prostate conditions. BPH symptoms include difficulty starting to relieve urinary symptoms, frequenting urination, and need to urinate often. In this article, we will help you develop a good hair cycle and make sure this product is right for you. We will also show you how to avoid hair loss during menopause and how to read and follow product directions. While Healthylife has not released any information about this product, you should not take it as you have read through the potential side effects associated with its use.
Healthylife has launched this new low dose version of Propecia, a medication widely used to treat hair loss. This product requires a prescription only because we have only select items for which we have a prescription. Please read product labels andileen. This is not a complete description of what is or is not possible with your current medications. Read product labels carefully and follow the instructions for use. If you are not sure whether a drug is available with your medications, contact your doctor or a pharmacist toll-free at bpharmacist.com.au.
Propecia has been shown to cause some mild side effects. Talk to your health care provider if these do not go away within a few days. If you begin to experience more serious reactions, seek medical attention immediately.
Common side effects reported from Propecia use include:
More serious side effects include:
If you experience any of these side effects, seek medical attention immediately. These are symptoms of a serious adverse reaction to this medication and require treatment right away.
As with all prescription medications, inform your doctor of any medical conditions you are currently managing. Tell them about any and all medications, prescription drugs, and supplements you are taking before starting treatment with Propecia. This includes all natural medications, including major depressive medications.
Propecia can interact with other medications it contains, such as lorazepam (lorna inhibitors) and, most recently, erazole (exhibessional). If you have these symptoms, consult your health care provider for possible health conditions related to these medications.
Tell your doctor if you are not sure whether any of your medications are affected by Propecia:, erlotinib (abacavir) (Gastroenter) (Genever) (Lonutch) (GlaxoSmithKline) (Jardiance) (Bayer) (Mylan) (Methandronus) (Heidelberg) (Heidelberg) (Mys projections) (Heidelberg) (Mys projections)
Please note: This is not a complete list of side effects. While this information is not major savings of any kind, it is considered “minors’” because other potential side effects may occur. It is important for you to discuss any existing medical conditions with our healthcare provider before starting Propecia. If you experience any serious side effects, please seek medical attention immediately.
What is finasteride? What is it used for? Propecia is a medication (finasteride) that belongs to a class of drugs called 5-alpha reductase inhibitors. It is taken to treat early-stage diffuse and advanced breast cancer and to reduce the risk of bone thinning in postmenopausal women. Dutasteride (Avodart) is used to treat benign prostatic hyperplasia (BPH) in men. Proscar (Avodart) is used to treat benign prostatic hyperplasia (BPH) in men. Daily use of Proscar may increase your risk of additional cancer diagnoses, including breast, prostate, or kidney cancer. Proscar should not be used in patients with a previous diagnosis of benign prostatic hyperplasia or with a diagnosis of an enlarged prostate.How is Propecia available? Propecia is usually prescribed by a doctor. The recommended dose of Propecia is one tablet (Proscar tablets) three times a day. You should take the medication at the same time each day, with the evening dat taking effect on the next dose. Propecia should not be taken more than once a day.
How is Propecia administered? Propecia is administered by mouth. You should swallow the medication whole, not in pill form, with a glass of water. Propecia oral suspension (Proscar liquid) is usually taken 30 minutes to 1 hour before sexual activity.
What are the possible side effects of Propecia? Some side effects may be mild and can be managed. The most common side effects are headache, back pain, muscle aches, and nausea. However, some people may experience a changes in appetite or weight such as dry mouth, upset stomach, or decreased appetite. Side effects generally require medical attention and are unlikely to occur in everyone taking Propecia. Side effects that occur in fewer than 1 in 10 people would be rarer such side effects.
You shouldraie finasteride tablet: Side effects reported primarily in women include headache, nausea, and vomiting. If you experience any serious side effects, seek medical attention immediately.
AstraZeneca, the world’s leading biopharmaceutical company, announced today that its US subsidiary, Aurobindo Pharma, has received approval from the U. S. Food and Drug Administration (FDA) to market Propecia® (finasteride) for the treatment of male pattern hair loss in the treatment of hair loss in men. The Propecia® brand is a 1 mg tablet taken once daily. Propecia® will be available in generic form, in 5 mg, 10 mg and 20 mg strengths.
“This approval demonstrates our continued commitment to advancing our understanding of male pattern hair loss and will help to further our goal of bringing men on the path to a successful sexual relationship. We continue to believe that our commitment to the public is paramount in promoting the growth and development of male sexual health,” said Aurobindo Pharma President and Chief Executive Officer, Dr. Andrew Wicker. “Our agreement with FDA is a testament to the strength of our product portfolio and our commitment to bringing new products to market.”
About male pattern hair loss
Male pattern hair loss (MPHL) is a condition that affects around one in 10 men worldwide and has been associated with reduced sex drive, depression, fatigue, mood and emotional problems.
The condition is characterized by thinning and loss of hair, and is most commonly associated with the frontal and/or temporal scalp areas, and the vertex areas, as well as the crown and the middle of the scalp. The hairline is thinner and shorter than the rest of the hair on the body, and the frontal area is less often affected.
About Aurobindo Pharma
Aurobindo Pharma, a world leader in pharmaceuticals and biopharma, today announced the FDA approvals for its Propecia® (finasteride) brand. Approved by the U. Food and Drug Administration (FDA), this oral tablet (1 mg) is FDA approved for the treatment of male pattern hair loss in men.
About Propecia
Propecia® is a 1 mg tablet taken once daily. It is taken once daily for 5 days every 4 months.
Aurobindo Pharma, the world’s leading biopharmaceutical company, today announced that it has received approval from the FDA to market Propecia® (finasteride) for the treatment of male pattern hair loss in the treatment of hair loss in men.
About Merck
Merck’s hair loss treatment products include Propecia® and Finasteride®.
Merck’s Propecia® and Finasteride® products are FDA approved for the treatment of male pattern hair loss in men.
About Merck & Company
Stade de France Pharmacy